Endothelin-1 increases superoxide production in human coronary artery bypass grafts

Life Sciences

Volumn 91, Issue 13-14, 2012, Pages 723-728

  Cerrato, R ^a   Cunnington, C ^b   Crabtree, M J ^b   Antoniades, C ^b   Pernow, J ^a   Channon, K M ^b   Bohm F ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Coronary bypass grafts; Endothelial dysfunction; Endothelin 1; Superoxide

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPHENYLIODONIUM SALT; ENDOTHELIN 1; LUCIGENIN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TIRON;

AGED; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONFOCAL MICROSCOPE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ELECTIVE SURGERY; FEMALE; FLUORESCENCE; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; MICROPHOTOGRAPHY; SAPHENOUS VEIN;

1,2-DIHYDROXYBENZENE-3,5-DISULFONIC ACID DISODIUM SALT; AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; ENDOTHELIN-1; FEMALE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MAMMARY ARTERIES; MIDDLE AGED; OLIGOPEPTIDES; ONIUM COMPOUNDS; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SAPHENOUS VEIN; SUPEROXIDES;

ANIMALIA; SIMPLEXVIRUS;

EID: 84867576024     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.03.024     Document Type: Conference Paper

References (42)

1. M. Barton, C.C. Haudenschild, L.V. d'Uscio, S. Shaw, K. Munter, and T.F. Luscher Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice Proc Natl Acad Sci USA 95 1998 14367 14372
2. J.K. Bendall, R. Rinze, D. Adlam, A.L. Tatham, J. de Bono, and N. Wilson Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice Circ Res 100 2007 1016 1025
3. F. Böhm, G. Ahlborg, and J. Pernow Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis Clin Sci (Lond) 102 2002 321 327
4. F. Böhm, B.L. Johansson, U. Hedin, K. Alving, and J. Pernow Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1 Atherosclerosis 160 2002 215 222
5. F. Böhm, and J. Pernow The importance of endothelin-1 for vascular dysfunction in cardiovascular disease Cardiovasc Res 76 2007 8 18
6. F. Böhm, M. Settergren, and J. Pernow Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo Atherosclerosis 190 2007 408 415
7. R.P. Brandes, M. Barton, K.M. Philippens, G. Schweitzer, and A. Mugge Endothelial-derived superoxide anions in pig coronary arteries: evidence from lucigenin chemiluminescence and histochemical techniques J Physiol 500 Pt2 1997 331 342 [Apr 15]
8. R.P. Brandes, N. Weissmann, and K. Schroder NADPH oxidases in cardiovascular disease Free Radic Biol Med 49 2010 687 706
9. T.M. Buetler, A. Krauskopf, and U.T. Ruegg Role of superoxide as a signaling molecule News Physiol Sci 19 2004 120 123
10. L.V. d'Uscio, M. Barton, S. Shaw, and T.F. Luscher Endothelin in atherosclerosis: importance of risk factors and therapeutic implications J Cardiovasc Pharmacol 35 4 Suppl 2 2000 S55-9
11. S. Dikalov, K.K. Griendling, and D.G. Harrison Measurement of reactive oxygen species in cardiovascular studies Hypertension 49 2007 717 727
12. F. Dong, X. Zhang, L.E. Wold, Q. Ren, Z. Zhang, and J. Ren Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1 Br J Pharmacol 145 2005 323 333
13. N. Duerrschmidt, N. Wippich, W. Goettsch, H.J. Broemme, and H. Morawietz Endothelin-1 induces NAD(P)H oxidase in human endothelial cells Biochem Biophys Res Commun 269 2000 713 717
14. A. Ergul, J.S. Johansen, C. Stromhaug, A.K. Harris, J. Hutchinson, and A. Tawfik Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1 J Pharmacol Exp Ther 313 2005 70 77
15. T.J. Guzik, and K.M. Channon Measurement of vascular reactive oxygen species production by chemiluminescence Methods Mol Med 108 2005 73 89
16. T.J. Guzik, S. Mussa, D. Gastaldi, J. Sadowski, C. Ratnatunga, and R. Pillai Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase Circulation 105 2002 1656 1662
17. T.J. Guzik, J. Sadowski, B. Guzik, A. Jopek, B. Kapelak, and P. Przybylowski Coronary artery superoxide production and nox isoform expression in human coronary artery disease Arterioscler Thromb Vasc Biol 26 2006 333 339
18. A. Hedman, P.T. Larsson, M. Alam, N.H. Wallen, R. Nordlander, and B.A. Samad CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? Int J Cardiol 120 2007 108 114
19. A. Heigl, M. Lachat, T. Lattmann, T. Luscher, and M. Barton Acute effects of 17 beta-oestradiol on functional activity of endothelin-converting enzymes in human arteries and veins Clin Sci (Lond) 103 Suppl. 48 2002 438S 441S
20. S. Heumuller, S. Wind, E. Barbosa-Sicard, H.H. Schmidt, R. Busse, and K. Schroder Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant Hypertension 51 2008 211 217
21. L.J. Ignarro, G.M. Buga, K.S. Wood, R.E. Byrns, and G. Chaudhuri Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide Proc Natl Acad Sci U S A 84 1987 9265 9269
22. A. Lerman, B.S. Edwards, J.W. Hallett, D.M. Heublein, S.M. Sandberg, and J.C. Burnett Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis N Engl J Med 325 1991 997 1001
23. A. Lerman, D.R. Holmes Jr., M.R. Bell, K.N. Garratt, R.A. Nishimura, and J.C. Burnett Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans Circulation 92 1995 2426 2431
24. T.L. Leto, S. Morand, D. Hurt, and T. Ueyama Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases Antioxid Redox Signal 11 2009 2607 2619
25. L. Li, Y. Chu, G.D. Fink, J.F. Engelhardt, D.D. Heistad, and A.F. Chen Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension Hypertension 42 2003 997 1003
26. L. Li, G.D. Fink, S.W. Watts, C.A. Northcott, J.J. Galligan, and P.J. Pagano Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension Circulation 107 2003 1053 1058
27. E.D. Loomis, J.C. Sullivan, D.A. Osmond, D.M. Pollock, and J.S. Pollock Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta J Pharmacol Exp Ther 315 2005 1058 1064
28. R. Lopez-Sepulveda, M. Gomez-Guzman, M.J. Zarzuelo, M. Romero, M. Sanchez, and A.M. Quintela Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: role of NADPH oxidase Clin Sci (Lond) 2010 321 333
29. A.C. Montezano, D. Burger, G.S. Ceravolo, H. Yusuf, M. Montero, and R.M. Touyz Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5 Clin Sci (Lond) 120 2011 131 141
30. T. Munzel, C. Sinning, F. Post, A. Warnholtz, and E. Schulz Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction Ann Med 40 2008 180 196
31. T.M. Paravicini, and R.M. Touyz NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities Diabetes Care 31 Suppl. 2 2008 S170 S180
32. M. Romero, R. Jimenez, M. Sanchez, R. Lopez-Sepulveda, A. Zarzuelo, and J. Tamargo Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation Atherosclerosis 212 2010 78 85
33. M.S. Sabatine, D.A. Morrow, J.A. de Lemos, T. Omland, S. Sloan, and P. Jarolim Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease Circulation 125 2012 233 240
34. E.L. Schiffrin Role of endothelin-1 in hypertension and vascular disease Am J Hypertens 14 2001 83S 89S
35. J. Stolk, T.J. Hiltermann, J.H. Dijkman, and A.J. Verhoeven Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol Am J Respir Cell Mol Biol 11 1994 95 102
36. A.J. Sutherland, M.I. Nataatmadja, P.J. Walker, L. Cuttle, R.B. Garlick, and M.J. West Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression Circulation 113 2006 1180 1188
37. R.M. Touyz Apocynin, NADPH oxidase, and vascular cells: a complex matter Hypertension 51 2008 172 174
38. R.M. Touyz, G. Yao, E. Viel, F. Amiri, and E.L. Schiffrin Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells J Hypertens 22 2004 1141 1149
39. A.E. Vendrov, Z.S. Hakim, N.R. Madamanchi, M. Rojas, C. Madamanchi, and M.S. Runge Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells Arterioscler Thromb Vasc Biol 27 2007 2714 2721
40. S. Verma, F. Lovren, A.S. Dumont, K.J. Mather, A. Maitland, and T.M. Kieser Endothelin receptor blockade improves endothelial function in human internal mammary arteries Cardiovasc Res 49 2001 146 151
41. S. Wind, K. Beuerlein, T. Eucker, H. Muller, P. Scheurer, and M.E. Armitage Comparative pharmacology of chemically distinct NADPH oxidase inhibitors Br J Pharmacol 161 2010 885 898
42. H.K. Yip, C.J. Wu, H.W. Chang, C.H. Yang, T.H. Yu, and Y.H. Chen Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty Chest 127 2005 1491 1497